Efficacy and Safety of Nebivolol (Added to Lisinopril or Losartan) in Hypertensive Patients

• Status: Completed
• Trial end date: 2010-05-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will assess blood pressure reduction with nebivolol or placebo in patients taking lisinopril or losartan.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Forest Laboratories
• Treatments: Lisinopril; Losartan; Nebivolol

Criteria

Inclusion Criteria:

• Male or female, ambulatory outpatients 18-85 years old at screening

• Have a history of hypertension

• Qualifying laboratory results

Exclusion Criteria:

• Severe hypertension, including chronic kidney disease

• Documented congestive heart failure

• Have clinically significant respiratory, liver, or heart disease

• History of stroke, heart attack, or heart surgery in the last 6 months

• Have a history of hypersensitivity to nebivolol or other beta blockers.